Myelodysplastic syndromes: 2023 update on diagnosis, risk‐stratification, and management
G Garcia‐Manero - American journal of hematology, 2023 - Wiley Online Library
Disease overview The myelodysplastic syndromes (MDS) are a very heterogeneous group
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management.
G Garcia-Manero - American Journal of Hematology, 2023 - europepmc.org
The myelodysplastic syndromes (MDS) are a very heterogeneous group of myeloid
disorders characterized by peripheral blood cytopenias and increased risk of transformation …
disorders characterized by peripheral blood cytopenias and increased risk of transformation …
Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management
G Garcia-Manero - American journal of hematology, 2023 - mdanderson.elsevierpure.com
Disease overview: The myelodysplastic syndromes (MDS) are a very heterogeneous group
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management
G Garcia-Manero - American journal of hematology, 2023 - pubmed.ncbi.nlm.nih.gov
Disease overview The myelodysplastic syndromes (MDS) are a very heterogeneous group
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …
of myeloid disorders characterized by peripheral blood cytopenias and increased risk of …